• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
oxycontin

Family Behind Purdue Pharma and OxyContin Faces Multiple Lawsuits

By
Renae Reints
Renae Reints
Down Arrow Button Icon
By
Renae Reints
Renae Reints
Down Arrow Button Icon
November 19, 2018, 4:07 PM ET

The Sackler family—members of which own Purdue Pharma, maker of the legal but highly addictive prescription painkiller OxyContin—is facing several lawsuits and a possible criminal investigation for its role in the opioid crisis, The Guardian reports.

Last month, New York’s Suffolk County filed a lawsuit that names eight Sackler family members across three generations who serve or have served on Purdue’s board. The lawsuit said the Sacklers “actively participated in conspiracy and fraud to portray the prescription painkiller as non-addictive, even though they knew it was dangerously addictive.”

The family has a net worth of $13 billion, according to Forbes.

“This is essentially a crime family … drug dealers in nice suits and dresses,” Paul Hanly, a New York City lawyer representing Suffolk County, told The Guardian. “What Purdue Pharma and the Sackler family have done to society through their aggressive peddling of opioids is unconscionable.”

In a statement to Fortune, Purdue Pharma said The Guardian‘s article “presents an inaccurate view of this complex legal matter,” adding that the “disinformation and ad hominem personal attacks” being put forth by the plaintiffs’ counsel only undermines real efforts to combat the opioid crisis, a “serious and complex public health problem.”

“The article relies heavily on comments from two contingency fee lawyers who are suing the Company for their own gain and who are willing to recklessly smear the reputations of companies and individuals in order to extract money in litigation,” the Purdue Pharma statement said of The Guardian‘s article. “Plaintiffs’ effort to name individual members of the Sackler family as defendants in the ongoing civil litigation is misguided and contradicts well established principles of law. These suits will be vigorously contested.”

Purdue Pharma and other opioid manufacturers are entangled in lawsuits across the country, with Purdue alone facing litigation from 30 states, according to The Guardian. In a 2007 case, Purdue executives unrelated to the Sacklers pleaded guilty to misleading doctors about OxyContin’s potential for abuse, resulting in Purdue paying out $600 million in fines.

Since then, the opioid crisis has only grown, with a record of nearly 72,000 people dying of drug overdose in 2017 alone.

Now, the family itself is facing a series of court battles. Along with the Suffolk County case, the Sacklers were sued by Massachusetts in June.

“For them it’s greed, it was all about profits over people,” Massachusetts attorney general Maura Healey told The Guardian. “I feel very confident naming the family members.”

The family members are also expected to be named in federal multi-district litigation in Ohio, and a source told The Guardian the family is also named in ongoing criminal investigations at the federal level. The Sacklers could not immediately be reached for comment.

Update: A statement from Purdue Pharma was added to this article after its initial publication.

About the Author
By Renae Reints
See full bioRight Arrow Button Icon

Latest in

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and everyone's now looking at the wrong alarm
By Eleanor PringleJanuary 31, 2026
3 days ago
placeholder alt text
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent all disease'
By Sydney LakeFebruary 1, 2026
2 days ago
placeholder alt text
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We are in trouble in our country'
By Marco Quiroz-GutierrezJanuary 31, 2026
3 days ago
placeholder alt text
Economy
Musk’s fantasy for a future where work is optional just got more real: U.K. minister calls for universal basic income to cushion AI-related job losses
By Sasha RogelbergFebruary 1, 2026
2 days ago
placeholder alt text
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By Emma BurleighFebruary 2, 2026
14 hours ago
placeholder alt text
Success
U.S. Olympic gold medalist went from $200,000-a-year sponsorship at 20 years old to $12-an-hour internship by 30
By Orianna Rosa RoyleFebruary 1, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in

EconomyManufacturing
Indonesia’s Danantara bets a new $6 billion SOE can save a textile industry from Trump tariffs and foreign competition
By Angelica AngFebruary 2, 2026
2 hours ago
karp
AIMarkets
‘We are an n of 1’: Palantir hails ‘incredible’ earnings as stock rockets nearly 8% after hours
By Nick LichtenbergFebruary 2, 2026
6 hours ago
Man speaking with a blue background.
AIElon Musk
Elon Musk’s SpaceX buys xAI in stunning deal valued at $1.25 trillion ahead of looming IPO
By Amanda GerutFebruary 2, 2026
7 hours ago
altman
AIMarkets
Oracle said it was ‘highly confident in OpenAI’s ability to raise funds and meet its commitments.’ Cue the stock fall
By Eva RoytburgFebruary 2, 2026
7 hours ago
The Ally logo on a green layered background.
Personal FinanceCertificates of Deposit (CDs)
Ally Bank CD rates 2026
By Joseph HostetlerFebruary 2, 2026
8 hours ago
EnergyDevon Energy
Devon Energy CEO: ‘Stars align’ to acquire Coterra for nearly $26 billion as merger mania returns to the oilfield
By Jordan BlumFebruary 2, 2026
9 hours ago